CCCC — C4 THERAPEUTICS INC

Ownership history in COMMONWEALTH EQUITY SERVICES, LLC  ·  14 quarters on record

This page tracks every 13F SEC filing in which COMMONWEALTH EQUITY SERVICES, LLC reported a position in C4 THERAPEUTICS INC (CCCC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 20,510 -601 -2.8% 0.00% $46K $2.22
2025 Q2 REDUCED 21,111 -4,989 -19.1% 0.00% $30K $1.43
2025 Q1 REDUCED 26,100 -2,780 -9.6% 0.00% $42K $1.60
2024 Q4 REDUCED 28,880 -6,290 -17.9% 0.00% $104K $3.60
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CCCC price (monthly, adj. close)

Other funds also holding CCCC

As of 2025 Q4 — sorted by position size

Lynx1 Capital Management LP 3Y 2.74% Bain Capital Life Sciences Investors, LLC 3Y 7Y 1.05% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.53% Soleus Capital Management, L.P. 3Y 0.27% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.16% INTREPID FAMILY OFFICE LLC 3Y 0.09% Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group 0.08% ORBIMED ADVISORS LLC 3Y 7Y 0.05% WASATCH ADVISORS LP 3Y 7Y 0.05% 683 Capital Management, LLC 3Y 7Y 0.03%
← Back to COMMONWEALTH EQUITY SERVICES, LLC Holdings